CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled proteomics and multimodal platform for decoding therapeutic secreted proteins on the “Leveraging Technology to Advance the Pipeline” panel at Longwood’s Boston CEO summit
CEO Dr. Hanadie Yousef was nominated to Founders Forum’s 100 Women Founders to Watch, which shines a light on 100 of the most exceptional women founders blazing a trail in the tech industry across UK & Europe, the United States, and Southeast Asia
Juvena is delighted to have had the opportunity to participate in our investor Bison’s AGM. CEO Dr. Yousef was on a panel focused on discussing the latest innovations in AI-driven drug discovery and development
CEO, Dr. Hanadie Yousef inspires the next generation of biotech entrepreneurs, in a fireside chat: Targeting the biology of aging to rejuvenate lives- Dr. Yousef’s journey through science research to launching Juvena for the Global Biotech Revolution
CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.
CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.
Juvena is selected by the World Economic Forum to join its 2024 global cohort of Technology Pioneers, awarded to the 100 most innovative tech startups applying new breakthroughs in AI to solve some of the biggest challenges of our time.
Juvena’s SVP of Translation, Dr. Mo Tabrizi participates in the Seattle Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.
